Whitehawk Therapeutics, Inc.
WHWK
$4.16
$0.051.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.55% | -31.02% | 66.27% | -172.06% | 499.58% |
| Total Depreciation and Amortization | 0.00% | -80.00% | -68.75% | -71.93% | 21.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.56% | -28.51% | -29.49% | 103.61% | -5,001.03% |
| Change in Net Operating Assets | -141.74% | 2,310.27% | 105.37% | -570.26% | -48.56% |
| Cash from Operations | -28.86% | -12.07% | 70.96% | -346.37% | 21.19% |
| Capital Expenditure | -- | -- | 100.00% | 99.82% | -196.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 100.00% | -- | -100.00% | -- |
| Other Investing Activities | 15.34% | 118.40% | -217.63% | -296.18% | 10.32% |
| Cash from Investing | 15.34% | 118.39% | -217.86% | -124.96% | 779.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -99.97% | 192,251.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 81.77% | -482,300.00% |
| Cash from Financing | -- | -- | 100.00% | -100.89% | 179,524.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -665.29% | 99.66% | -29.49% | -141.56% | 10,749.97% |